CLEARSIDE BIOMEDICAL INC (CLSD)

US1850631045 - Common Stock

1.28  +0.05 (+4.07%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
ASSETS
Current Assets
Cash Equivalents
28.92M48.26M30.44M17.29M22.60M
Marketable Securities
N/AN/AN/AN/A0.00
Receivables
170.00K0.0010.00MN/AN/A
Other Current Assets
1.03M1.14M1.70M830.00K2.63M
Total Current Assets
30.12M49.40M42.14M18.12M25.22M
 
Non-Current Assets
PPE Net
3.87M1.87M610.00K940.00K1.20M
Other Non-Current Assets
30.00K30.00K160.00K260.00K360.00K
Total Non-Current Assets
3.90M1.90M760.00K1.20M1.56M
 
TOTAL ASSETS
34.02M51.30M42.90M19.32M26.78M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Current Portion Of LT Debt.
N/AN/A0.00990.00K1.33M
Accrued Expenses
4.53M4.53M3.70M1.96M3.29M
Accounts Payable
2.21M1.05M940.00K2.00M1.28M
Other Current Liabilities
75.00K210.00K0.005.00M5.00M
Total Current Liabilities
6.81M5.78M4.64M9.94M10.90M
 
Non-Current Liabilities
Long Term Debt
0.000.000.000.003.82M
Other Non-Current Liabilities
43.12M34.91M290.00K620.00K900.00K
Total Non-Current Liabilities
43.12M34.92M290.00K620.00K4.72M
 
TOTAL LIABILITIES
49.93M40.70M4.93M10.56M15.62M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-320.92M-288.44M-255.49M-255.87M-237.66M
Additional Paid In Capital
304.95M298.98M293.41M264.58M248.77M
Common Shares
63.00K60.00K60.00K50.00K40.00K
Other Shareholders' Equity
N/AN/AN/AN/AN/A
Shares Outstanding
62.85M60.64M59.72M51.86M44.41M
Tangible Book Value per Share
-0.250.170.640.170.25
Total Shareholders' Equity
-15.91M10.61M37.98M8.76M11.16M
 
TOTAL LIABILITIES AND EQUITY
34.02M51.30M42.90M19.32M26.78M
 
Statistics
Debt/Equity
N/AN/AN/AN/A0.34
Current Ratio
4.428.559.081.822.31
Return On Assets (ROA)
-95.49%-64.23%0.89%-94.25%-114.90%
Return On Equity (ROE)
N/A-310.56%1.00%-207.88%-275.72%

All data in USD

Charts